Haw Par Corporation Limited (SGX: H02)

Market Cap	2.47B
Revenue (ttm)	239.06M
Net Income (ttm)	234.43M
Shares Out	221.37M
EPS (ttm)	1.06
PE Ratio	10.55
Forward PE	n/a
Dividend	0.40 (3.57%)
Ex-Dividend Date	Aug 22, 2024

Volume	6,100
Open	11.12
Previous Close	11.19
Day's Range	11.12 - 11.16
52-Week Range	9.44 - 11.35
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Haw Par Corporation

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1969
• Employees: 595
• Stock Exchange: Singapore Exchange
• Ticker Symbol: H02

Financial Performance

In 2023, Haw Par Corporation's revenue was 232.06 million, an increase of 27.44% compared to the previous year's 182.09 million. Earnings were 216.57 million, an increase of 46.02%.